V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006117 | 220002378 | 1.72 | 56.4 | Disease modification (D) | 2015-09-02 | 2015-09-02 | AML 19 TRIAL | 1 | N | 220029650 | AML19 TRIAL |
| 220006118 | 220011336 | 0 | 0 | Curative (C) | 2018-09-08 | 2018-09-08 | Nilotinib | N | N | 220029651 | NILOTINIB |
| 220006119 | 220002379 | 1.57 | null | Disease modification (D) | 2017-06-07 | 2017-06-22 | Nilotinib | N | N | 220029652 | NILOTINIB |
| 220006120 | 220011337 | 1.57 | 61.4 | Curative (C) | 2016-06-10 | 2016-06-10 | AML 19 TRIAL | Y | N | 220029657 | AML19 TRIAL |
| 220006121 | 220011337 | 1.67 | 83.7 | Curative (C) | 2016-06-26 | 2016-06-30 | AML 19 TRIAL | 01 | null | 220029657 | AML19 TRIAL |
| 220006122 | 220011337 | 1.7 | 81.8 | Disease modification (D) | 2017-07-31 | 2017-09-13 | FLAG + Idarubicin | N | N | 220029657 | FLAG + IDARUBICIN |
| 220006123 | 220002380 | 1.78 | 50 | Curative (C) | 2014-03-21 | 2014-03-23 | FBC Conditionining | 1 | N | 220029662 | NOT MATCHED |
| 220006124 | 220002380 | 1.79 | 81.6 | Curative (C) | 2015-03-27 | 2015-03-27 | AML 19 TRIAL | null | null | 220029662 | AML19 TRIAL |
| 220006125 | 220002380 | 0 | 79 | Curative (C) | 2013-03-25 | 2013-06-20 | Nilotinib | N | N | 220029662 | NILOTINIB |
| 220006126 | 220002381 | null | 73.15 | Neo-adjuvant (N) | 2016-06-13 | 2016-06-13 | APML Consolidation II ATRA,Idarubicin | 1 | N | 220029666 | NOT MATCHED |
| 220006127 | 220002381 | null | null | Disease modification (D) | 2013-06-20 | 2013-06-20 | Nilotinib | N | N | 220029666 | NILOTINIB |
| 220006128 | 220002382 | null | 0 | Curative (C) | 2017-01-18 | 2017-01-18 | Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE | null | null | 220029668 | NOT MATCHED |
| 220006129 | 220002382 | 1.6 | 72.1 | Curative (C) | 2014-05-17 | 2014-05-18 | FLAG + Idarubicin | N | N | 220029668 | FLAG + IDARUBICIN |
| 220006130 | 220002382 | 1.74 | 103 | Curative (C) | 2017-01-16 | 2017-01-25 | AML MyeChild 01 A Mitozantrone/Cytarabine | Y | N | 220029668 | NOT MATCHED |
| 220006133 | 220002384 | null | 53.5 | Neo-adjuvant (N) | 2014-03-22 | 2014-03-30 | Nilotinib | N | null | 220029677 | NILOTINIB |
| 220006134 | 220002384 | null | 78 | Disease modification (D) | 2015-06-16 | 2015-06-19 | Nilotinib | 2 | N | 220029677 | NILOTINIB |
| 220006135 | 220002384 | 1.61 | 79 | Curative (C) | 2017-04-23 | 2017-04-23 | AML 19 TRIAL | 01 | null | 220029677 | AML19 TRIAL |
| 220006136 | 220002385 | 1.49 | 0 | Palliative (P) | 2017-11-07 | 2017-11-12 | Nilotinib | 02 | N | 220029685 | NILOTINIB |
| 220006137 | 220002385 | null | 33.9 | Neo-adjuvant (N) | 2016-11-09 | 2016-11-12 | AML MyeChild | N | N | 220029685 | NOT MATCHED |
| 220006138 | 220002385 | 1.72 | 101 | Curative (C) | 2017-06-14 | 2017-06-14 | FLAG + Idarubicin | 02 | null | 220029685 | FLAG + IDARUBICIN |
| 220006139 | 220002385 | null | 0 | Disease modification (D) | 2014-06-24 | 2014-06-24 | Nilotinib | N | N | 220029685 | NILOTINIB |
| 220006140 | 220002385 | 1.72 | 79.3 | Curative (C) | 2014-04-09 | 2014-04-09 | FLAG + Idarubicin | N | N | 220029685 | FLAG + IDARUBICIN |
| 220006141 | 220002385 | 1.58 | 75 | Curative (C) | null | 2015-04-29 | FLAG + Idarubicin | Y | N | 220029685 | FLAG + IDARUBICIN |
| 220006142 | 220002386 | null | 61 | Curative (C) | 2017-08-18 | 2017-08-20 | FLAG + Idarubicin | N | N | 220029701 | FLAG + IDARUBICIN |
| 220006145 | 220016090 | 0 | 79 | Palliative (P) | 2016-11-11 | 2016-11-30 | Nilotinib | 2 | N | 220029705 | NILOTINIB |
| 220006146 | 220016090 | null | null | Palliative (P) | 2014-04-01 | 2014-04-02 | Nilotinib | N | N | 220029705 | NILOTINIB |
| 220006147 | 220002388 | 0 | 0 | Palliative (P) | 2015-04-03 | 2015-04-04 | Nilotinib | N | N | 220029708 | NILOTINIB |
| 220006148 | 220002388 | 1.64 | null | Disease modification (D) | 2014-01-28 | 2014-01-31 | Nilotinib | 02 | N | 220029708 | NILOTINIB |
| 220006151 | 220002390 | 0 | 63 | Curative (C) | 2017-09-04 | 2017-09-04 | Nilotinib | N | N | 220029715 | NILOTINIB |
| 220006152 | 220002390 | 0 | 0 | Disease modification (D) | 2014-03-10 | 2014-03-10 | Nilotinib | null | N | 220029715 | NILOTINIB |
| 220006153 | 220002390 | 0 | 0 | Disease modification (D) | 2014-07-09 | 2014-07-11 | Nilotinib | N | N | 220029715 | NILOTINIB |
| 220006161 | 220002393 | null | null | Palliative (P) | null | 2016-10-16 | AML Interim Guidelines FLAG-Ida | 02 | N | 220029739 | FLAG + IDARUBICIN |
| 220006162 | 220002394 | null | 63.8 | null | 2014-03-04 | 2014-03-05 | FLAG + Idarubicin | 01 | N | 220029740 | FLAG + IDARUBICIN |
| 220006163 | 220002394 | 1.67 | 80.2 | Curative (C) | 2014-11-26 | 2014-12-03 | FLAG + Idarubicin | 2 | N | 220029740 | FLAG + IDARUBICIN |
| 220006164 | 220002394 | null | 0 | Curative (C) | 2017-03-18 | 2017-03-28 | Nilotinib | N | N | 220029740 | NILOTINIB |
| 220006165 | 220002395 | null | 83.8 | Neo-adjuvant (N) | 2016-02-13 | 2016-02-13 | Nilotinib | N | N | 220029747 | NILOTINIB |
| 220006166 | 220002396 | 0 | null | Curative (C) | null | 2013-02-15 | Nilotinib | N | N | 220029749 | NILOTINIB |
| 220006167 | 220002396 | null | 83 | Curative (C) | 2013-07-11 | 2013-07-21 | CML Dasatinib | N | N | 220029749 | NOT MATCHED |
| 220006168 | 220002396 | null | null | null | 2014-01-24 | 2014-01-24 | Nilotinib | 02 | N | 220029749 | NILOTINIB |
| 220006169 | 220002396 | 1.61 | 76.3 | Curative (C) | 2018-01-09 | 2018-01-09 | AML 19 TRIAL | Y | N | 220029749 | AML19 TRIAL |
| 220006170 | 220002396 | 1.74 | 68.3 | Curative (C) | 2017-08-02 | 2017-08-04 | AML 19 TRIAL | 1 | N | 220029749 | AML19 TRIAL |
| 220006171 | 220002397 | 1.71 | null | null | null | 2014-11-06 | FLAG + Idarubicin | 02 | N | 220029756 | FLAG + IDARUBICIN |
| 220006172 | 220002398 | 1.9 | 0 | Curative (C) | 2014-10-20 | 2014-11-04 | Nilotinib | N | N | 220029760 | NILOTINIB |
| 220006175 | 220002400 | 1.87 | 72.1 | Adjuvant (A) | 2016-10-29 | 2016-10-29 | FLAG + Idarubicin | 2 | N | 220029766 | FLAG + IDARUBICIN |
| 220006176 | 220011353 | 0 | 98 | Not known (9) | 2014-07-13 | 2014-07-13 | Nilotinib | 02 | N | 220029768 | NILOTINIB |
| 220006177 | 220016096 | 1.68 | 6 | Curative (C) | null | 2015-06-10 | FLAG + Idarubicin | N | N | 220029769 | FLAG + IDARUBICIN |
| 220006178 | 220016096 | null | 85 | Disease modification (D) | 2016-09-18 | 2016-09-18 | Nilotinib | N | N | 220029769 | NILOTINIB |
| 220006179 | 220016096 | null | 28.8 | Curative (C) | 2014-12-14 | 2014-12-15 | Idarubicin + Tretinoin (Induction course) | Y | null | 220029769 | NOT MATCHED |
| 220006180 | 220002401 | null | 60.4 | Curative (C) | 2014-09-03 | 2014-09-03 | APML HR Ind ATO + ATRA | Y | N | 220029772 | NOT MATCHED |
| 220006181 | 220011354 | 1.7 | 77.2 | Curative (C) | 2015-04-28 | 2015-04-28 | FLAG + Idarubicin | N | N | 220029773 | FLAG + IDARUBICIN |